Intelerad Medical Systems, a medical imaging software company, has agreed to acquire Ambra Health, a cloud-based medical imaging software provider.
Intelerad, backed by European buyout firm Hg, will pay more than $250 million for Ambra Health, according to Bloomberg. According to a press statement, combining the two company’s medical imaging platforms will give doctors, patients, and researchers the ability to read, store, and share diagnostic imaging over the cloud.
Intelerad’s medical imaging software platform is used by radiologists primarily outside of hospitals to access and analyze images like CT scans, X-rays, and MRIs.
Ambra medical imaging software platform is used by some of the largest health systems – such as Johns Hopkins Medicine, Memorial Hermann, New York Presbyterian, radiology practices, subspecialty practices, and clinical research organizations – to improve imaging and collaborative care workflows. Ambra’s cloud-based platform enables radiologists and other care providers to share and view images in real-time, improving patient engagement, continuity of care, and interoperability.
“The ultimate goal of healthcare is for human beings to live longer, healthier lives. Medical imaging and advanced technology are critical to this goal, and this acquisition positions Intelerad to enhance imaging accessibility and empower healthcare providers with the tools they need to deliver better patient outcomes,” said Mike Lipps, Intelerad Chief Executive Officer.
“For healthcare providers, moving to the cloud is not a matter of if, but when. Partnering with Ambra is a significant milestone on our path to provide the most scalable and robust medical image management platform in the industry. And while many medical imaging vendors offer pieces of what providers need, Intelerad now offers the entire solution.”
One hundred thirty-six digital health companies were acquired in the first half of 2021 compared to 83 in 1H 2020. In February, Intelerad Medical Systems acquired cardiovascular intelligence software company Lumedx for an undisclosed amount.
